AcelRx Pharmaceuticals Inc. said Timothy Morris resigned as CFO and head of business development of the company.
AcelRx CEO Vincent Angotti will take over Morris' duties on an interim basis.
Discover more about S&P Global’s offerings
AcelRx CFO resigns
Insight Weekly: M&A outlook; US community bank margins; green hydrogen players' EU expansion
Global M&A by the Numbers: Q2 2022
Insight Weekly: US bank M&A; low refinancing eases rates impact; Texas crypto mining booms
Infographic 2022 Top Tech Trends Shaping Corporations
AcelRx Pharmaceuticals Inc. said Timothy Morris resigned as CFO and head of business development of the company.
AcelRx CEO Vincent Angotti will take over Morris' duties on an interim basis.